The epidemiology of non-Hodgkin lymphoma

Pathology

Volumn 37, Issue 6, 2005, Pages 409-419

  Grulich, Andrew E ^a   Vajdic, Claire M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Epidemiology; Non Hodgkin lymphoma

Indexed keywords

ALCOHOL; HERBICIDE; PESTICIDE; SEX HORMONE; SOLVENT; TOXIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL CONSUMPTION; ALLERGIC DISEASE; APPENDECTOMY; ATOPY; AUSTRALIA; AUTOIMMUNE DISEASE; BIRTH ORDER; BLOOD TRANSFUSION; CELIAC DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; EPSTEIN BARR VIRUS; ETHNIC DIFFERENCE; FOLLICULAR LYMPHOMA; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; IONIZING RADIATION; LIFESTYLE; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; NEOPLASM; NONHODGKIN LYMPHOMA; NUTRITION; OBESITY; OCCUPATIONAL EXPOSURE; PHYSICAL ACTIVITY; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE; SIMIAN VIRUS 40; SJOEGREN SYNDROME; SMOKING; STOMACH MUCOSA; SUN EXPOSURE; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL LEUKEMIA; T CELL LYMPHOMA; TONSILLECTOMY; TRANSPLANTATION; VACCINATION;

EID: 29744453475     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020500370192     Document Type: Article

References (147)

1. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer in Australia 2001. Canberra: AIHW, 2004. (Cancer Series No. 28.)
2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
3. Jaffe ES, Harris NL, Stein H, et al. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lympoid Tissues. Lyon: IARC, 2001.
4. The Non-Hodgkin Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-35.
5. Stansfeld AG, Diebodl J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292-3.
6. Hartge P, Devesa SS, Fraumeni JF Jr. Hodgkin and non-Hodgkin lymphomas. Cancer Surv 1994; 19-20: 423-53.
7. Devesa SS, Fears T. Non-Hodgkin lymphoma time trends: United States and international data. Cancer Res 1992; 52: 5432s-40s.
8. Carli PM, Boutron MC, Maynadie M, et al. Increase in the incidence of non-Hodgkin lymphomas: evidence for a recent sharp increase in France independent of AIDS. Br J Cancer 1994; 70: 713-5.
9. Gurney KA, Cartwright RA. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematology J 2002; 3: 95-104.
10. Parkin DM, Whelan SL, Ferlay J, et al, editors. Cancer Incidence in Five Continents. Volume VIII. Lyon: International Agency for Research on Cancer (IARC), 2003. IARC Scientific Publication No. 155.
11. Scherr PA, Mueller NE. Non-Hodgkin lymphoma. In: Schottenfeld D, Fraumeni J Jr, editors. Cancer Epidemiology and Prevention. New York: Oxford University Press, 1996; 920-45.
12. McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin lymphoma? Br J Cancer 1996; 73: 945-50.
13. Bentham G. Association between incidence of non-Hodgkin lymphoma and solar ultraviolet radiation in England and Wales. BMJ 1996; 312: 1128-31.
14. Hartge P, Devesa SS, Grauman D, et al. Non-Hodgkin lymphoma and sunlight. J Natl Cancer Inst 1996; 88: 298-300.
15. Newton R. Solar ultraviolet radiation is not a major cause of primary cutaneous non-Hodgkin lymphoma. BMJ 1997; 314: 1483-4.
16. Adami J, Frisch M, Yuen J, et al. Evidence of an association between non-Hodgkin lymphoma and skin cancer. BMJ 1995; 310: 1491-5.
17. Boffetta P, Butler J, Maynadie M, et al. Lymphomas. In: Neuget A.I, Meadows A.T, Robinson E, editors. Multiple Primary Cancers. Philadelphia: Lippincott Williams and Wilkins, 1999.
18. Brennan P, Coates M, Armstrong B, et al. Second primary neoplasms following non-Hodgkin lymphoma in New South Wales, Australia. Br J Cancer 2000; 82: 1344-7.
19. Cartwright R, McNally R, Staines A. The increasing incidence of non-Hodgkin lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 1994; 14: 387-94.
20. Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005; 14: 925-33.
21. Morton LM, Zheng T, Holford T, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 2005; 6: 469-76.
22. Hoover R, Fraumeni JF. Risk of cancer in renal transplant recipients. Lancet 1973; 2: 55-7.
23. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995; 60: 1485-91.
24. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514-6.
25. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4: 222-30.
26. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995; 60: 183-9.
27. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-7.
28. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-13.
29. Disney APS. Complications of immunosuppressive therapy in transplantation. 1. Neoplasia and infection. Med J Aust 1992; 157: 262-4.
30. Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784-9.
31. Mueller N. Overview of the epidemiology of malignancy in immune deficiency. JAIDS 1999; 21: S5-10.
32. Disney APS, editor. Fourteenth Report of the Australian and New Zealand Dialysis and Transplant Registry. Adelaide: Queen Elizabeth Hospital: 1991.
33. Levy M, Backman L, Husberg B, et al. De novo malignancy following liver transplantation: a single center study. Transplantation Proc 1993; 25: 1397-9.
34. Kamel OW, Van de Rijn M, Weiss LM, et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Eng J Med 1993; 328: 1317-21.
35. Morse HC, Hartley JW, Tang Y, et al. Lymphoproliferation as a precursor to neoplasia: what is a lymphoma? In: Minson A, Neil J, McCrae M, editors. Viruses and Cancer. Cambridge: Cambridge University Press, 1994; 265-91.
36. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996; 14: 1943-9.
37. Kinlen L. Immunosuppressive therapy and cancer. Cancer Surv 1982; 1: 565-83.
38. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Int Med 1993; 19: 1093-104.
39. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Lymphoproliferative diseases in renal allograft recipients. In: Purtilo D.T, editor. Immune Deficiency and Cancer. New York: Plenum Medical Book Company, 1984; 321-47.
40. Kinlen LJ. Immunosuppression and cancer. In: Vainio H, Magee P.N, McGregor D.B, et al, editors. Mechanisms of Carcinogenesis in Risk Identification. Lyon: IARC, 1992; 237-53.
41. Beral V, Peterman T, Berkelman R, et al. AIDS-associated non-Hodgkin lymphoma. Lancet 1991; 337: 805-9.
42. Grulich A, Wan X, Law M, et al. Risk of cancer in people with AIDS. AIDS 1999; 13: 839-43.
43. Franceschi S, Dal Maso L, La Vecchia C. Advances in the epidemiology of HIV-associated non-Hodgkin lymphoma and other lymphoid neoplasms. Int J Cancer 1999; 83: 481-5.
44. Grulich AE, Wan X, Law MG, et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin lymphoma in people with AIDS. AIDS 2000; 14: 133-40.
45. Burkes RL, Meyer PR, Gill PS, et al. Rectal lymphoma in homosexual men. Arch Int Med 1986; 146: 913-5.
46. Morris JDH, Eddleston ALWF, Crook T. Viral infection and cancer. Lancet 1995; 346: 754-8.
47. Grulich AE. AIDS-associated non-Hodgkin lymphoma in the era of HAART. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 21: S27-30.
48. Grulich AE, Li Y, McDonald AM, et al. Decreasing rates of HIV-associated Kaposi's sarcoma and non-Hodgkin lymphoma in the era of highly active anti-retroviral therapy. AIDS 2001; 15: 629-33.
49. Newell ME, Hoy JF, Cooper SG, et al. Human immunodeficiency virus related primary central nervous system lymphoma: factors influencing survival in 111 cases. Cancer 2004; 100: 2627-36.
50. Filipovich AH, Mathur A, Kamat D, et al. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992; 52: 5465s-7s.
51. Mueller BU, Pizzo PA. Cancer in children with primary or secondary immunodeficiencies. J Pediatrics 1995; 126: 1-10.
52. Harrington DS, Weisenburger DD, Purtilo DT. Malignant lymphoma in the X linked lymphoproliferative syndrome. Cancer 1987; 59: 1419-29.
53. Purtilo DT, Luka J, Brichacek B, et al. Non-Hodgkin lymphoma in X-linked lymphoproliferative disease. In: Tursz T, Pagano JS, Ablashi DV, et al, editors. The Epstein-Barr Virus and Associated Diseases. Montrouge: John Libbey Eurotext, 1993; 419-23.
54. Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78: 44-9.
55. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 307-1.
56. Ekstrom K, Hjalgrim H, Brandt L, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 2003; 48: 963-70.
57. Askling J, Fored M, Baecklund E, et al. Hematopoietic malignancies in rheumatoid arthritis. Lymphoma risk and characteristics following TNF-antagonists. Ann Rheum Dis 2005; 64: 1414-20. (Epub 2005 Apr 20.)
58. Kauppi M, Pukkala E, Isomaki H. Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997; 8: 201-4.
59. Baecklund E, Ekbom A, Sparen P, et al. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 1998; 317: 180-1.
60. Askling J, Klareskog L, Hjalgrim H, et al. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis. Ann Rheum Dis 2005; Apr 20: (Epub ahead of print).
61. Bjornadal L, Lofstrom B, Yin L, et al. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 66-71.
62. Bernatsky S, Ramsey-Goldman R, Clarke A. Exploring the links between systemic lupus erythematosus and cancer. Rheum Dis Clin North Am 2005; 31: 387-402.
63. Hannuksela-Svahn A, Pukkala E, Laara E, et al. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol 2000; 114: 587-90.
64. Gelfand JM, Berlin J, Van Voorhees A, et al. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol 2003; 139: 1425-9.
65. Smedby KE, Akerman M, Hildebrand H, et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005; 54: 54-9.
66. Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287: 1413-9.
67. Askling J, Brandt L, Lapidus A, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 2005; 54: 617-22.
68. Tielsch JM, Linet MS, Szklo M. Acquired disorders affecting the immune system and non-Hodgkin lymphoma. Prev Med 1987; 16: 96-106.
69. Cartwright RA, McKinney PA, O'Brien C, et al. Non-Hodgkin lymphoma: case control epidemiological study in Yorkshire. Leuk Res 1988; 12: 81-8.
70. Franceschi S, Serraino D, Bidoli E, et al. The epidemiology of non-Hodgkin lymphoma in the north-east of Italy: a hospital-based case-control study. Leuk Res 1989; 13: 465-72.
71. La Vecchia C, Negri E, Franceschi S. Medical history and the risk of non-Hodgkin lymphomas. Cancer Epidemiol Biomarkers Prev 1992; 1: 533-6.
72. Tavani A, La Vecchia C, Franceschi S, et al. Medical history and risk of Hodgkin and non-Hodgkin lymphomas. Eur J Cancer Prev 2000; 9: 59-64.
73. Holly EA, Lele C, Bracci PM, et al. Case-control study of non-Hodgkin lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999; 150: 375-89.
74. Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res 1992; 52: 5510s-5s.
75. Doody MM, Linet MS, Glass AG, et al. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control 1992; 3: 449-56.
76. Vineis P, Crosignani P, Sacerdote C, et al. Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health 2000; 54: 431-6.
77. Holly EA, Bracci PM. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 2003; 158: 316-27.
78. Briggs NC, Levine RS, Brann EA. Allergies and risk of non-Hodgkin lymphoma by subtype. Cancer Epidemiol Biomarkers Prev 2002; 11: 401-7.
79. Holly EA, Lele C, Bracci P. Non-Hodgkin lymphoma in homosexual men in the San Francisco Bay Area: occupational, chemical, and environmental exposures. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 223-31.
80. Strachan DP. Family size, inferction and atopy: the first decade of the 'hygiene hypothesis'. Thorax 2000; 55 (Suppl 1): S2-10.
81. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-60.
82. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1: 69-75.
83. Holly EA, Lele C. Non-Hodgkin lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 211-22.
84. Paffenbarger RS Jr, Wing AL, Hyde RT. Characteristics in youth predictive of adult-onset malignant lymphomas, melanomas, and leukemias: brief communication. J Natl Cancer Inst 1978; 60: 89-92.
85. Vineis P, Miligi L, Crosignani P, et al. Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health 2000; 54: 907-11.
86. Grulich AE, Vajdic CM, Kaldor JM, et al. Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2005; 97: 587-94.
87. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350: 1328-37.
88. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Vol 70. Lyon: IARC, 1997; 1-492.
89. Helicobacter and Cancer Collaborative Group, Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-53.
90. de Sanjose S, Dickie A, Alvaro T, et al. Helicobacter pylori and malignant lymphoma in Spain. Cancer Epidemiol Biomarkers Prev 2004; 1: 944-8.
91. Wotherspoon C, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lympoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-8.
92. Manns A, Cleghorn FR, Falk RT, et al. Role of HTLV-1 in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. Lancet 1993; 342: 1447-50.
93. Middleton GW, Lau RK. AIDS lymphomas. Int J STD AIDS 1992; 3: 173-81.
94. Musto P. Hepatitis C virus infection and B-cell non-Hodgkin lymphomas: more than a simple association. Clin Lymphoma 2002; 3: 150-60.
95. Rabkin CS, Tess BH, Christianson RE, et al. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 4240-2.
96. Engels EA, Chatterjee N, Cerhan JR, et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004; 111: 76-80.
97. Grulich AE, Olsen S, Hendry O, et al. Kaposi's sarcoma associated herpesvirus: A sexually transmissible infection? J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 387-93.
98. Grulich AE, Cunningham P, Munier MLC, et al. Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia. Sexual Health 2005; 2: 13-8.
99. Cannon M, Cesarman E. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy. Semin Oncol 2000; 27: 409-19.
100. Engels EA, Katki HA, Nielsen NM, et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003; 95: 532-9.
101. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817-23.
102. Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002; 359: 851-2.
103. MacKenzie J, Wilson KS, Perry J, et al. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J Natl Cancer Inst 2003; 95: 1001-3.
104. de Sanjose S, Shah KV, Domingo-Domenech E, et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 2003; 104: 522-4.
105. Jaffe ES. Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. J Natl Cancer Inst 2004; 96: 571-3.
106. Ferreri A, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004; 96: 586-94.
107. Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350: 239-48.
108. Cerroni L, Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457-61.
109. Cerhan JR, Anderson KE, Janney CA, et al. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer 2003; 20: 784-8.
110. Adami J, Gridley G, Nyren O, et al. Sunlight and non-Hodgkin lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999; 80: 641-5.
111. Zhang SM, Giovannucci EL, Hunter DJ, et al. Vitamin supplement use and the risk of non-Hodgkin lymphoma among women and men. Am J Epidemiol 2001; 153: 1056-63.
112. La Vecchia C, Negri E, Franceschi S. Education and cancer risk. Cancer 1992; 70: 2935-41.
113. De Roos AJ, Zahm SH, Cantor KP, et al. Integrative assessment of multiple pesticides as risk factors for non-Hodgkin lymphoma among men. Occup Environ Med 2003; 60: E11.
114. Rothman N, Cantor KP, Blair A, et al. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 1997; 350: 240-4.
115. Cantor KP, Strickland PT, Brock JW, et al. Risk of non-Hodgkin lymphoma and prediagnostic serum organochlorines: beta-hexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachlorobenzene. Environ Health Perspect 2003; 111: 179-83.
116. Khuder SA, Schaub EA, Keller-Byrne JE. Meta-analyses of non-Hodgkin lymphoma and farming. Scand J Work Environ Health 1998; 24: 255-61.
117. Wong O, Raabe GK. Non-Hodgkin lymphoma and exposure to benzene in a multinational cohort of more than 308,000 petroleum workers, 1937 to 1996. J Occup Environ Med 2000; 42: 554-68.
118. Fritschi L, Benke G, Hughes AM, et al. Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia). Cancer Causes Control 2005; 16: 599-607.
119. Correa A, Jackson L, Mohan A, et al. Use of hair dyes, hematopoietic neoplasms, and lymphomas: a literature review. II Lymphomas and multiple myeloma. Cancer Invest 2000; 18: 467-79.
120. La Vecchia C, Tavani A. Hair dyes and lympoid neoplasms: an update. Eur J Cancer Prev 2002; 11: 409-12.
121. Hughes AM, Armstrong BK, Vajdic CM, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004; 112: 865-71.
122. Smedby KE, Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005; 97: 199-209.
123. Scherr PA, Hutchison GB, Neiman RS. Non-Hodgkin lymphoma and occupational exposure. Cancer Res 1992; 52: 5503s-9s.
124. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin lymphoma: composite (threefold) case-control study. BMJ 1997; 314: 1451-5.
125. Van Wijngaarden E, Savitz DA. Occupational sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Med 2001; 43: 548-553.
126. Cerhan JR, Wallace RB, Dick F, et al. Blood transfusions and risk of non-Hodgkin lymphoma subtypes and chronic lymphocytic leukemia. Cancer Epidemiol Biomarker Prev 2001; 10: 361-8.
127. Zhu J, Zhu K, Levine RS, et al. Letters to the editor, re 'Blood transfusions as a risk factor for non-Hodgkin lymphoma in the San Francisco Bay Area: a population-based study. Am J Epi 2003; 157: 1052-3.
128. Cope JU, Askling J, Gridley G, et al. Appendectomy during childhood and adolescence and the subsequent risk of cancer in Sweden. Pediatrics 2003; 111: 1343-50.
129. Cerhan JR, Wallace RB, Folsom AR, et al. Medical history risk factors for non-Hodgkin lymphoma in older women. J Natl Cancer Inst 1997; 89: 314-8.
130. Weiderpass E, Gridley G, Ekbom A, et al. Medical history risk factors for non-Hodgkin lymphoma in older women. J Natl Cancer Inst 1997; 89: 816-7.
131. Askling J, Ekbom A. Risk of non-Hodgkin lymphoma following tuberculosis. Br J Cancer 2001; 84: 113-5.
132. Levine R, Zhu K, Gu Y, et al. Self-reported infectious mononucleosis and 6 cancers: a population-based, case-control study. Scand J Infect Dis 1998; 30: 211-4.
133. Peach HG, Barnett NE. Critical review of epidemiological studies of the association smoking and non-Hodgkin lymphoma. Hematological Oncology 2001; 19: 67-80.
134. Briggs NC, Levine RS, Bobo LD, et al. Wine drinking and risk of non-Hodgkin lymphoma among men in the United States: a population-based case-control study. Am J Epidemiol 2002; 156: 454-62.
135. Cerhan JR, Janney CA, Vachon CM, et al. Anthropometric characteristics, physical activity, and risk of non-Hodgkin lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 2002; 156: 527-35.
136. Chang ET, Hjalgrim H, Smedby KE, et al. Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 2005; 97: 210-8.
137. Chiu BC-H, Cerhan JR, Folsom AR, et al. Diet and risk of non-Hodgkin lymphoma in older women. JAMA 1996; 275: 1315-21.
138. Zhang S, Hunter DJ, Rosner BA, et al. Dietary fat and protein in relation to risk of non-Hodgkin lymphoma among women. J Natl Cancer Inst 1999; 91: 1751-8.
139. Fernandez E, Chatenoud L, La Vecchia C, et al. Fish consumption and cancer risk. Am J Clin Nutr 1999; 70: 85-90.
140. Zhang SM, Hunter DJ, Rosner BA, et al. Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin lymphoma among women. Cancer Epidemiol Biomarker Prev 2000; 9: 477-85.
141. Zhang SM, Calle EE, Petrelli JM, et al. Vitamin supplement use and fatal non-Hodgkin lymphoma among US men and women. Am J Epidemiol 2001; 153: 1064-70.
142. Zheng W, Doyle TJ, Kushi LH, et al. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 1996; 144: 175-82.
143. Tavani A, Pregnolato A, Negri E, et al. Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 1997; 27: 256-60.
144. Weyer PJ, Cerhan JR, Kross BC, et al. Municipal drinking water nitrate level and cancer risk in older women: the Iowa Women's Health Study. Epidemiology 2001; 12: 327-38.
145. Cerhan JR, Habermann TM, Vachon CM, et al. Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa Women's Health Study (United States). Cancer Causes Control 2002; 13: 131-6.
146. Cerhan JR, Vachon CM, Habermann TM, et al. Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarker Prev 2002; 11: 1466-71.
147. Linet MS, Pottern LM. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin lymphoma. Cancer Res 1992; 52: 5468s-5473s.